Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol
Fei Chen,
Jinghe Lang,
Peter Hillemanns,
Youzhong Zhang,
Zoltán Novák,
Long Sui,
Ling Han,
Christian Dannecker,
Ctirad Mokráš,
Zhixue You
Affiliations
Fei Chen
Harbour Biomed, Shanghai, China
Jinghe Lang
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China
Peter Hillemanns
10 Department of Gynecology and Obstetrics, Medizinische Hochschule, Hannover, Germany
Youzhong Zhang
Departments of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Zoltán Novák
Department of Obstetrics and Gynecology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary; and
Long Sui
Obstetrics & Gynecology Hospital of Fudan University, Shanghai, PR China.
Ling Han
Department of Oncology, Tianjin Beichen Hospital, Tianjin, China
Christian Dannecker
Department of Obstetrics and Gynaecology, University Hospital Augsburg, Augsburg, Germany
Ctirad Mokráš
MCM GYNPED, s.r.o, Dubnica nad Vahom, Slovakia
Zhixue You
Department of Obstetrics and Gynecology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China
